2019
DOI: 10.1002/14651858.cd003506.pub2
|View full text |Cite
|
Sign up to set email alerts
|

Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer

Abstract: Analysis 2.2. Comparison 2 Early vs deferred AST (subgroup analyses based on disease stage), Outcome 2 Serious adverse events based on disease stage..

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0
2

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(21 citation statements)
references
References 134 publications
0
18
0
2
Order By: Relevance
“…Literature searches in electronic databases were the same for each rapid review, but three different investigators independently screened the literature and scanned the reference lists for relevant studies. For each rapid review, we used the same key questions and eligibility criteria as the Cochrane reviews [16][17][18]. We randomly assigned the topic order to rapid reviewers to mitigate learning effects.…”
Section: General Methodological Approachmentioning
confidence: 99%
See 2 more Smart Citations
“…Literature searches in electronic databases were the same for each rapid review, but three different investigators independently screened the literature and scanned the reference lists for relevant studies. For each rapid review, we used the same key questions and eligibility criteria as the Cochrane reviews [16][17][18]. We randomly assigned the topic order to rapid reviewers to mitigate learning effects.…”
Section: General Methodological Approachmentioning
confidence: 99%
“…We decided to use Cochrane reviews as comparators because they adhere to rigorous systematic review methodological standards [19]. Two of these reviews addressed the pharmacological treatments of malignant diseases (nivolumab for Hodgkin's lymphoma [16] and early versus deferred androgen suppression for advanced prostate cancer [18]); the third review was on a public health policy topic (unconditional cash transfers for reducing poverty and vulnerabilities [17]). We used ongoing reviews so that investigators conducting the rapid reviews were masked regarding the final inclusions of the Cochrane reviews.…”
Section: Reference Standardsmentioning
confidence: 99%
See 1 more Smart Citation
“…We decided to use Cochrane reviews as comparators because they adhere to a rigorous systematic review of methodological standards [19]. Two of these reviews addressed the pharmacological treatments of malignant diseases (nivolumab for Hodgkin's lymphoma [16] and early versus deferred androgen suppression for advanced prostate cancer [18]); the third review was on a public health policy topic (unconditional cash transfers for reducing poverty and vulnerabilities [17]). We used ongoing reviews so that investigators conducting the rapid reviews were masked regarding the final inclusions of the Cochrane reviews.…”
Section: Reference Standardsmentioning
confidence: 99%
“…For case study 3, the reference list searches identified 3 to 4 studies that had been missed by the abbreviated electronic literature searches (see Table 3). In Table 2 Characteristics of the Cochrane reviews used as reference standards Case study 1: Nivolumab for adult individuals with Hodgkin's lymphoma [16] Case study 2: Early versus deferred androgen suppression for treating advanced prostate cancer [18] Case study 3: Unconditional cash transfers for reducing poverty and vulnerabilities [17] Search Studies included in meta-analyses 0 1 0 1 1…”
Section: Sensitivity To Identify Relevant Studiesmentioning
confidence: 99%